The following are excerpts from the newsletter

April 18, 2013

  • QuarterWatch (April 2013 issue) Perspective on GLP-1 agents for diabetes
  • When a compounding pharmacy “registers” with FDA, what does it mean?
    Presently, there is no requirement for compounding pharmacies to register with the US Food and Drug Administration (FDA), and there are no FDA-specified procedures that must be followed by compounding pharmacies to ensure safety. Some compounding pharmacies do register with FDA, but this does not mean that it is routinely inspected by FDA nor does “FDA-registered” mean that FDA has reviewed or approved any compounded preparations produced by the pharmacy.

  • Safety Briefs: Account for overfill with IV chemotherapy
    More than 1,100 patients in Canada may have received lower doses of chemotherapy as a compounding pharmacy and the hospitals it supplied did not have a common understanding of the amount of overfill in the containers that resulted from the chemotherapy additive and the volume of overfill inherent in commercially available IV bags

  • Message in our mailbox: Keypads on smart pumps
    For infusion pumps that use a numeric keypad, the vast majority of companies have adopted the configuration of a telephone keypad.

Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas
  - Free Nursing CEs
Special Alerts
Group Purchasing Subscription
Newsletter Editions
Acute Care
Community/Ambulatory Care
Nurse AdviseERR
Long-Term Care AdviseERR
Safe Medicine
Home | Contact UsEmployment  |   Legal Notices | Privacy Policy | Help Support ISMP
 Med-ERRS | Medication Safety Officer Society Medication Safety Officers Society | Consumer Medication Safety For consumers
ISMP Canada | ISMP Spain  | ISMP Brasil  | International Group  | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2018 Institute for Safe Medication Practices. All rights reserved